Wave Life Sciences in a Tuesday filing with the SEC said Takeda has elected to terminate its option to continue work on ...

Takeda is walking away from the last target in a collaboration with Wave Life Scien | Takeda has brandished a termination ...

Wave Life Sciences (NASDAQ:WVE) said Takeda (NYSE:TAK) has elected not to exercise its option to further develop its ...

Wave Life Sciences' WVE-006 study shows significant promise in treating alpha-1 antitrypsin deficiency. Learn more about WVE ...

There is no simple solution to tackling health inequity, but we’re confident that infusing health equity principles across ...

Takeda Pharmaceutical offers a strong cash position and an above-average dividend yield. Find out why I'm bullish on TAK ...

Wave Life Sciences has taken a step toward validating a new modality, becoming the first group to report therapeutic RNA ...

Loh led a Willenken team that won a $505.6 million award for AbbVie Pharmaceuticals in a breach-of-contract dispute with ...

Pharmaceutical company Lupin has announced a non-exclusive patent licence agreement with Takeda Pharmaceutical for the ...

The vaccine began being administered through the public health sysem in February this year. It was prioritized for children ...

Takeda, a global pharmaceutical leader, is celebrating a decade in Vietnam, emphasizing its commitment to improving ...

Gastrointestinal virtual care company Oshi Health announced a $60 million series C round led by Oak HC/FT.  | Virtual GI care ...